http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9511909-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-003 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate | 1994-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d72fccd0445e0f2698acc738ec0b740c |
| publicationDate | 1995-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9511909-A1 |
| titleOfInvention | Peptide-based nucleic acid surrogates |
| abstract | The present invention relates to the development of a new class of oligonucleotide surrogates capable of sequence specific binding to simple stranded DNA and RNA as well as to double stranded DNA targets. More specifically, structures (Ser/Thr[CH2B]-AA[P])n below represent the repeating structural units for a number of the nucleic acid surrogates of the present invention. Once synthesized (in suitably protected form), the monobasic units are linked together via peptide bonds to produce the required oligomeric structures having defined nucleobase sequences. These nucleic acid surrogates may then be utilized for use as antisense/antigene probes and/or drug carriers. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0777678-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6204326-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0777678-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5831014-A |
| priorityDate | 1993-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.